1-3 of 3
Daniel C. Link
Close
Sort by
Journal Articles

Genomic landscape of TP53 -mutated myeloid malignancies

Haley J. Abel, Karolyn A. Oetjen, Christopher A. Miller, Sai M. Ramakrishnan, Ryan B. Day, Nichole M. Helton, Catrina C. Fronick, Robert S. Fulton, Sharon E. Heath, Stefan P. Tarnawsky, Sridhar Nonavinkere Srivatsan, Eric J. Duncavage, Molly C. Schroeder, Jacqueline E. Payton, David H. Spencer, Matthew J. Walter, Peter Westervelt, John F. DiPersio, Timothy J. Ley, Daniel C. Link
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4586–4598.
https://doi.org/10.1182/bloodadvances.2023010156
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor

Clinical Trials & Observations
David C. Dale, Audrey Anna Bolyard, James A. Shannon, IV, James A. Connelly, Daniel C. Link, Mary Ann Bonilla, Peter E. Newburger
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3861–3869.
https://doi.org/10.1182/bloodadvances.2021005684
Published: 2022
Includes: Supplemental data
Journal Articles

Expression profiling of snoRNAs in normal hematopoiesis and AML

Wayne A. Warner, David H. Spencer, Maria Trissal, Brian S. White, Nichole Helton, Timothy J. Ley, Daniel C. Link
Journal: Blood Advances
Blood Adv (2018) 2 (2): 151–163.
https://doi.org/10.1182/bloodadvances.2017006668
Published: 2018
Includes: Supplemental data